Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Danielle Antin-Ozerkis, MD
Yale University
Principal Investigator - Gail Weinmann, MD
National Heart, Lung, and Blood Institute (NHLBI)
Study Director - Gerald Criner, MD
Temple University
Principal Investigator - Imre Noth, MD
University of Chicago
Principal Investigator - Ivan Rosas, MD
Brigham and Women's
Principal Investigator - James Loyd, MD
Vanderbilt University
Principal Investigator - Jay Ryu, MD
Mayo Clinic
Principal Investigator - Jeffrey Chapman, MD
The Cleveland Clinic
Principal Investigator - Joao deAndrade, MD
University of Alabama at Birmingham
Principal Investigator - Joe Lasky, MD
Tulane University
Principal Investigator - John Fitzgerald, MD
University of Texas
Principal Investigator - Joseph Zibrak, MD
Beth Isreal-Deaconess
Principal Investigator - Kevin Anstrom, PhD
Duke University
Principal Investigator - Marvin I Schwarz, MD
University of Colorado, Denver
Study Chair - Michael Kallay, MD
Highland Hospital
Principal Investigator - Milton Rossman, MD
University of Pennsylvania
Principal Investigator - Neil Ettinger, MD
St. Luke's Hospital
Principal Investigator - Rob Kaner, MD
Weill Medical College at Cornell University
Principal Investigator - Steven Sahn, MD
Medical University of South Carolina
Principal Investigator - Talmadge King, MD
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama - Birmingham
Birmingham, Alabama, United States
- University of California - Los Angeles
Los Angeles, California, United States
- University of California - San Francisco
San Francisco, California, United States
- National Jewish Medical and Research Center
Denver, Colorado, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- University of Miami Miller School of Medicine
Miami, Florida, United States
- University of Chicago
Chicago, Illinois, United States
- University of Louisville
Louisville, Kentucky, United States
- Tulane University
New Orleans, Louisiana, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- St. Luke'S Hospital
Chesterfield, Missouri, United States
- Mount Sinai Hospital
New York, New York, United States
- Weill Medical College of Cornell University
New York, New York, United States
- Highland Hospital - University of Rochester Medical Center
Rochester, New York, United States
- Duke Universtiy
Durham, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Temple University
Philadelphia, Pennsylvania, United States
- University of Pennsylvania Health System
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Vanderbilt University
Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- University of Utah Health Research Center
Salt Lake City, Utah, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2009
- Primary completion
- 31 Oct 2013
- Completion
- 31 Jan 2014
- Last update posted
- 2 Jun 2015
- Registered enrollment
- 264
- Registry id
- NCT00650091
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.